Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6961 AL 6975

Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease

Pyka P, Garbo S, Fioravanti R, Jacob C, Hittinger M, Handzlik J, Zwergel C, Battistelli C.

Drug Discov Today. 2024 Aug;29(8):104062. doi: 10.1016/j.drudis.2024.104062. Epub 2024 Jun 11.

Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees

Fung KW, Baye F, Baik SH, McDonald CJ.

PLoS One. 2024 Aug 22;19(8):e0309222. doi: 10.1371/journal.pone.0309222. eCollection 2024.

Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review

Yuan J, Dong X, Zhou S, Nao J.

Neuroscience. 2024 Dec 17;563:136-147. doi: 10.1016/j.neuroscience.2024.10.048. Epub 2024 Nov 1.

The Effects of Chiropractic Spinal Adjustment on EEG in Adults with Alzheimer's and Parkinson's Disease: A Pilot Randomised Cross-over Trial

Navid MS, Niazi IK, Holt K, Nedergaard RB, Amjad I, Ghani U, Kumari N, Shafique M, Duehr J, Trager RJ, Haavik H.

J Integr Neurosci. 2024 May 11;23(5):98. doi: 10.31083/j.jin2305098.

Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease

Singulani MP, Ferreira AFF, Figueroa PS, Cuyul-Vásquez I, Talib LL, Britto LR, Forlenza OV.

Ageing Res Rev. 2024 Mar;95:102231. doi: 10.1016/j.arr.2024.102231. Epub 2024 Feb 15.

Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers

Ansari MA, Tripathi T, Venkidasamy B, Monziani A, Rajakumar G, Alomary MN, Alyahya SA, Onimus O, D'souza N, Barkat MA, Al-Suhaimi EA, Samynathan R, Thiruvengadam M.

Mol Neurobiol. 2024 May;61(5):3042-3089. doi: 10.1007/s12035-023-03730-z. Epub 2023 Nov 15.

Application of CRISPR/Cas9 System in the Treatment of Alzheimer's Disease and Neurodegenerative Diseases

Rahimi A, Sameei P, Mousavi S, Ghaderi K, Hassani A, Hassani S, Alipour S.

Mol Neurobiol. 2024 Nov;61(11):9416-9431. doi: 10.1007/s12035-024-04143-2. Epub 2024 Apr 19.

Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems

Roghani AK, Garcia RI, Roghani A, Reddy A, Khemka S, Reddy RP, Pattoor V, Jacob M, Reddy PH, Sehar U.

Ageing Res Rev. 2024 Jun;97:102291. doi: 10.1016/j.arr.2024.102291. Epub 2024 Apr 12.

Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases

Carles A, Freyssin A, Perin-Dureau F, Rubinstenn G, Maurice T.

Int J Mol Sci. 2024 Mar 27;25(7):3733. doi: 10.3390/ijms25073733.

Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease

Akyuz E, Aslan FS, Gokce E, Ilmaz O, Topcu F, Kakac S.

Eur J Neurosci. 2024 Oct;60(8):6057-6090. doi: 10.1111/ejn.16541. Epub 2024 Sep 19.

Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases

Saleem A, Javed M, Akhtar MF, Sharif A, Akhtar B, Naveed M, Saleem U, Baig MMFA, Zubair HM, Bin Emran T, Saleem M, Ashraf GM.

Curr Gene Ther. 2024;24(2):122-134. doi: 10.2174/0115665232261931231006103234.

Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS

Toader C, Tataru CP, Munteanu O, Serban M, Covache-Busuioc RA, Ciurea AV, Enyedi M.

Int J Mol Sci. 2024 Nov 24;25(23):12613. doi: 10.3390/ijms252312613.

Developing effective educational approaches for Liaison Old Age Psychiatry teams: a literature review of the learning needs of hospital staff in relation to managing the confused older patient

Teodorczuk A, Welfare M, Corbett S, Mukaetova-Ladinska E.

Int Psychogeriatr. 2010 Sep;22(6):874-85. doi: 10.1017/S1041610209991475. Epub 2009 Dec 15.

The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects

Sleegers K, Lambert JC, Bertram L, Cruts M, Amouyel P, Van Broeckhoven C.

Trends Genet. 2010 Feb;26(2):84-93. doi: 10.1016/j.tig.2009.12.004. Epub 2010 Jan 18.

Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations

Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R.

J Alzheimers Dis. 2010;20(1):301-11. doi: 10.3233/JAD-2010-1362.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias